In cases of severe eclampsia and gestational hypertension, reduced mRNA expression of MFSD2A (2A containing the major facilitator superfamily structural domain) in the placenta may lead to increased maternal DHA levels and reduced fetal DHA exposure, possibly due to compromised placental transfer mechanisms [12,47]. The gene discussed is MFSD2A; the disease is preeclampsia.